The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Cheryl Cooper.
DIGEST
SB 84 Original 2021 Regular Session Talbot
Proposed law requires any health coverage plan renewed, delivered, or issued for delivery, in this
state include coverage for the cost of genetic or molecular cancer testing including but not limited
to tumor mutation testing, next generation sequencing, hereditary germline mutation testing,
pharmacogenomic testing, whole exome, and genome sequencing.
Proposed law authorizes the coverage for genetic cancer testing to be subject to annual deductibles,
coinsurance, and copayments.
Proposed law defines health coverage plan as any hospital, health, or medical expense insurance
policy, hospital or medical service contract, employee welfare benefit plan, contract, or other
agreement with a health maintenance organization or a preferred provider organization, health and
accident insurance policy, or any other insurance contract of this type in the state, including group
insurance plans, self-insurance plans, and the office of group benefits programs. Excludes a plan
providing coverage for excepted benefits in present law, limited benefit health insurance plans, and
short-term policies that have a term of less than 12 months.
Proposed law applies to health coverage plans renewed, delivered, or issued for delivery in their state
on or after January 1, 2022.
Effective January 1, 2022.
(Adds R.S. 22:1028.3)